Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib + Radiotherapy in Locally Advanced NSCLC
NCT01091376Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jan 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01091376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091376.